Supernus Pharmaceuticals, Inc.: Trokendi Xr, Topiramate Extended-release Capsules, 25mg, 30 Capsules
Supernus Pharmaceuticals is recalling 25mg Trokendi XR (topiramate extended-release) capsules in 30-count bottles because the medication failed to dissolve properly in the body as specified. The affected product was distributed nationwide across all U.S. states and territories. This is a Class III recall, meaning use of the product is unlikely to cause serious health problems, but the medication may not work as intended.
- Recalling firm
- Supernus Pharmaceuticals, Inc.
- Product
- Trokendi XR, topiramate extended-release capsules, 25mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391 USA, Manufactured for: Supernus Pharmaceuticals, Inc., Rockville, MD 20850 USA, NDC 17772-101-30.
- Reason
- Failed Dissolution Specifications
- Classification
- Class III
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-07-06
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- US Nationwide.
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/a6910e63-82bc-45e0-b315-09b0b5b519f4